Cargando…

Irisflorentin improves α-synuclein accumulation and attenuates 6-OHDA-induced dopaminergic neuron degeneration, implication for Parkinson’s disease therapy

Parkinson’s disease (PD) is a degenerative disorder of the central nervous system that is characterized by progressive loss of dopaminergic neurons in the substantia nigra pars compacta as well as motor impairment. Aggregation of α-synuclein in neuronal cells plays a key role in this disease. At pre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yue-Mi, Liu, Shih-Ping, Lin, Hsin-Lien, Chan, Ming-Chia, Chen, Yen-Chuan, Huang, Yu-Ling, Tsai, Min-Chen, Fu, Ru-Huei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	China Medical University 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4326644/ https://www.ncbi.nlm.nih.gov/pubmed/25705584 http://dx.doi.org/10.7603/s40681-015-0004-y

Ejemplares similares

n-Butylidenephthalide Protects against Dopaminergic Neuron Degeneration and α-Synuclein Accumulation in Caenorhabditis elegans Models of Parkinson's Disease
por: Fu, Ru-Huei, et al.
Publicado: (2014)

Glycine-Alanine Dipeptide Repeat Protein from C9-ALS Interacts with Sulfide Quinone Oxidoreductase (SQOR) to Induce the Activity of the NLRP3 Inflammasome in HMC3 Microglia: Irisflorentin Reverses This Interaction
por: Fu, Ru-Huei, et al.
Publicado: (2023)

Infections of Cryptococcus species induce degeneration of dopaminergic neurons and accumulation of α-Synuclein in Caenorhabditis elegans
por: Kitisin, Thitinan, et al.
Publicado: (2022)

Neuroprotective Capability of Narcissoside in 6-OHDA-Exposed Parkinson’s Disease Models through Enhancing the MiR200a/Nrf-2/GSH Axis and Mediating MAPK/Akt Associated Signaling Pathway
por: Fu, Ru-Huei, et al.
Publicado: (2022)

Substantia Nigra Hyperechogenicity Reflects the Progression of Dopaminergic Neurodegeneration in 6-OHDA Rat Model of Parkinson’s Disease
por: Zhang, Siyan, et al.
Publicado: (2020)

Hypoxic stress accelerates the propagation of pathological alpha‐synuclein and degeneration of dopaminergic neurons
por: Guo, Mengyuan, et al.
Publicado: (2022)

Astrocytic Expression of GSTA4 Is Associated to Dopaminergic Neuroprotection in a Rat 6-OHDA Model of Parkinson’s Disease
por: Jewett, Michael, et al.
Publicado: (2017)

Echinacoside's nigrostriatal dopaminergic protection against 6‐OHDA‐Induced endoplasmic reticulum stress through reducing the accumulation of Seipin
por: Zhang, Yajie, et al.
Publicado: (2017)

IGF2 prevents dopaminergic neuronal loss and decreases intracellular alpha-synuclein accumulation in Parkinson’s disease models
por: Arcos, Javiera, et al.
Publicado: (2023)

Nitrated α–Synuclein Immunity Accelerates Degeneration of Nigral Dopaminergic Neurons
por: Benner, Eric J., et al.
Publicado: (2008)

Neuroprotective effects of edaravone-administration on 6-OHDA-treated dopaminergic neurons
por: Ji Yuan, Wen, et al.
Publicado: (2008)

The Parkinsonian mimetic, 6-OHDA, impairs axonal transport in dopaminergic axons
por: Lu, Xi, et al.
Publicado: (2014)

Effects of Treadmill Exercise on the Recovery of Dopaminergic Neuron Loss and Muscle Atrophy in the 6-OHDA Lesioned Parkinson's Disease Rat Model
por: Choe, Myoung-Ae, et al.
Publicado: (2012)

Electroacupuncture Promotes Recovery of Motor Function and Reduces Dopaminergic Neuron Degeneration in Rodent Models of Parkinson’s Disease
por: Lin, Jaung-Geng, et al.
Publicado: (2017)

Peiminine Reduces ARTS-Mediated Degradation of XIAP by Modulating the PINK1/Parkin Pathway to Ameliorate 6-Hydroxydopamine Toxicity and α-Synuclein Accumulation in Parkinson’s Disease Models In Vivo and In Vitro
por: Hsu, Yu-Ling, et al.
Publicado: (2021)

Asymmetric Dopaminergic Degeneration and Attentional Resources in Parkinson’s Disease
por: Ortelli, Paola, et al.
Publicado: (2018)

Alpha-Synuclein Disrupted Dopamine Homeostasis Leads to Dopaminergic Neuron Degeneration in Caenorhabditis elegans
por: Cao, Pengxiu, et al.
Publicado: (2010)

Optogenetic Rescue of Locomotor Dysfunction and Dopaminergic Degeneration Caused by Alpha-Synuclein and EKO Genes
por: Qi, Cheng, et al.
Publicado: (2017)

α-synuclein overexpression in the retina leads to vision impairment and degeneration of dopaminergic amacrine cells
por: Marrocco, Elena, et al.
Publicado: (2020)

Measuring dopaminergic function in the 6-OHDA-lesioned rat: a comparison of PET and microdialysis
por: Walker, Matthew D, et al.
Publicado: (2013)

DA5-CH and Semaglutide Protect against Neurodegeneration and Reduce α-Synuclein Levels in the 6-OHDA Parkinson's Disease Rat Model
por: Zhang, Lingyu, et al.
Publicado: (2022)

Neuroprotective effects of kukoamine A on 6-OHDA-induced Parkinson's model through apoptosis and iron accumulation inhibition
por: Li, Xin, et al.
Publicado: (2020)

P2X4R Overexpression Upregulates Interleukin-6 and Exacerbates 6-OHDA-Induced Dopaminergic Degeneration in a Rat Model of PD
por: Ma, Jiangnan, et al.
Publicado: (2020)

Degeneration of Dopaminergic Neurons Due to Metabolic Alterations and Parkinson’s Disease
por: Song, Juhyun, et al.
Publicado: (2016)

Targeted inhibition of RAGE in substantia nigra of rats blocks 6-OHDA–induced dopaminergic denervation
por: Gasparotto, Juciano, et al.
Publicado: (2017)

SKP-SCs transplantation alleviates 6-OHDA-induced dopaminergic neuronal injury by modulating autophagy
por: Ma, Chengxiao, et al.
Publicado: (2021)

Prolonged Dysfunction of Astrocytes and Activation of Microglia Accelerate Degeneration of Dopaminergic Neurons in the Rat Substantia Nigra and Block Compensation of Early Motor Dysfunction Induced by 6-OHDA
por: Kuter, Katarzyna, et al.
Publicado: (2017)

Mangosteen Pericarp Extract Supplementation Boosts Antioxidant Status via Rebuilding Gut Microbiota to Attenuate Motor Deficit in 6-OHDA-Induced Parkinson’s Disease
por: Nurrahma, Bira Arumndari, et al.
Publicado: (2022)

Glucose-Dependent Insulinotropic Polypeptide Mitigates 6-OHDA-Induced Behavioral Impairments in Parkinsonian Rats
por: Yu, Yu-Wen, et al.
Publicado: (2018)

Tetraspanin (TSP-17) Protects Dopaminergic Neurons against 6-OHDA-Induced Neurodegeneration in C. elegans
por: Masoudi, Neda, et al.
Publicado: (2014)

Baicalein prevents 6-OHDA/ascorbic acid-induced calcium-dependent dopaminergic neuronal cell death
por: Wang, Sheng-Fang, et al.
Publicado: (2017)

FOXA1 transcription activates TFF1 to reduce 6-OHDA-induced dopaminergic neuron damage
por: Liang, Tingting, et al.
Publicado: (2022)

Acyl-Ghrelin Attenuates Neurochemical and Motor Deficits in the 6-OHDA Model of Parkinson’s Disease
por: Rees, Daniel, et al.
Publicado: (2022)

Grafts Derived from an α-Synuclein Triplication Patient Mediate Functional Recovery but Develop Disease-Associated Pathology in the 6-OHDA Model of Parkinson’s Disease
por: Shrigley, Shelby, et al.
Publicado: (2021)

Clinical Features Indicating Nigrostriatal Dopaminergic Degeneration in Drug-Induced Parkinsonism
por: Lee, Seung Ha, et al.
Publicado: (2017)

The Effect of Human Umbilical Cord Mesenchymal Stromal Cells in Protection of Dopaminergic Neurons from Apoptosis by Reducing Oxidative Stress in the Early Stage of a 6-OHDA-Induced Parkinson’s Disease Model
por: Chi, Heng, et al.
Publicado: (2019)

The Convergence of Alpha-Synuclein, Mitochondrial, and Lysosomal Pathways in Vulnerability of Midbrain Dopaminergic Neurons in Parkinson’s Disease
por: Minakaki, Georgia, et al.
Publicado: (2020)

BMP5/7 protect dopaminergic neurons in an α-synuclein mouse model of Parkinson’s disease
por: Vitic, Zagorka, et al.
Publicado: (2020)

Optogenetic induction of alpha-synuclein aggregation in human dopaminergic neurons to model Parkinson’s disease pathology
por: Ra, Eun A., et al.
Publicado: (2023)

Dyrk1a Phosphorylation of α-Synuclein Mediating Apoptosis of Dopaminergic Neurons in Parkinson's Disease
por: Yong, Yuxuan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1cgnhgfq9j6vatlob4f6go3f1e